ORACLE(TM) CORONARY BALLOON DILATATION CATHETER

FDA Premarket Approval P910031

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceORACLE(TM) CORONARY BALLOON DILATATION CATHETER
Generic NameCatheters, Transluminal Coronary Angioplasty, Percutaneous
ApplicantABBOTT VASCULAR DEVICES
Date Received1991-06-07
Decision Date1994-09-30
Notice Date1994-12-15
PMAP910031
SupplementS
Product CodeLOX 
Docket Number94M-0402
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT VASCULAR DEVICES 400 Saginaw Dr. redwood City, CA 94063

Supplemental Filings

Supplement NumberDateSupplement Type
P910031Original Filing
S026 2009-07-29 30-day Notice
S025
S024 2007-05-04 Normal 180 Day Track No User Fee
S023 2004-11-16 Normal 180 Day Track
S022 2004-11-01 Normal 180 Day Track
S021 2001-12-06 Normal 180 Day Track
S020
S019 1998-06-15 Normal 180 Day Track
S018
S017 1997-10-14 Real-time Process
S016 1997-05-22 Real-time Process
S015 1997-03-28 Normal 180 Day Track
S014
S013
S012 1996-09-30 Normal 180 Day Track
S011 1996-08-26 Normal 180 Day Track
S010 1996-07-23 Normal 180 Day Track
S009 1996-05-15 Normal 180 Day Track
S008 1996-02-09 Normal 180 Day Track
S007 1996-01-26 Normal 180 Day Track
S006 1995-11-03 Normal 180 Day Track
S005 1995-09-07 Normal 180 Day Track
S004 1995-08-18 Normal 180 Day Track
S003 1995-06-02 Normal 180 Day Track
S002 1995-03-30 Normal 180 Day Track
S001 1994-11-21 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.